Developing and Evaluating a Digital Intervention Aiming to Support Informal Caregivers of People With Dementia

NCT07248241 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-12-12

No results posted yet for this study

Summary

The goal of this feasibility trial is to test the acceptability and feasibility of a new digital education pro-gram, the Caregiver Education Resource for Dementia (CARE-Dem). This is a behavioral (non-medical) intervention, designed to support informal caregivers of people with dementia. The primary purpose is to explore whether this program can help improve wellbeing and reduce burden among informal caregivers. The study focuses on adult caregivers, such as spouses, partners, relatives, or close friends of people recently diagnosed with dementia or living with mild dementia.

The main questions it aims to answer are:

* Is it possible to recruit and retain caregivers to participate in this type of digital intervention?
* Do participants find the program relevant, useful, and acceptable? Are the study procedures and outcome measures (such as questionnaires) suitable and manage-able for the participants?
* Does the intervention show preliminary signs of reducing caregiver burden and improving care-givers' wellbeing, knowledge, quality of relationship with the person with dementia, ability to ac-cept the situation, and feelings of being capable of managing their caregiving role? Researchers will compare caregivers who receive the CARE-Dem program with a control group who are offered the usual municipal information sessions. This allows us to see whether the digital pro-gram is feasible and whether it shows signs of effect compared with standard practice.

Participants in the intervention group will be asked to:

• Use the CARE-Dem digital platform over a three-month period.

The platform includes three modules:

Module 1: Understanding dementia and medical treatment options Module 2: Everyday life and communication with a person with dementia Module 3: Legal and practical matters, and information on support available in the community

* Engage with a mix of learning materials such as short videos, fact sheets, interactive activities, guides, and links to further resources
* Complete questionnaires at baseline and after 3 months to measure caregiver burden, wellbeing, and self-efficacy
* Take part in qualitative interviews about their experiences with the program, including usability, satisfaction, acquired knowledge, benefits, and suggestions for improvement.

Participants in the control group will receive treatment as usual. They will be offered to take part in existing information sessions provided by the municipalities, but attendance is optional. Researchers will record whether or not they attend, in order to compare results across subgroups.

This feasibility trial will help determine whether it is possible to run a larger evaluation of the CARE-Dem program in the future. If successful, the program could provide flexible and accessible support to the many caregivers of people with dementia, reaching those who cannot attend traditional in-person sessions.

Conditions

  • Dementia Caregiver
  • Digital Education Interventions

Interventions

BEHAVIORAL

Digital support tool

The CARE-Dem digital support tool offers a number of modules that participants must complete within three months.

Sponsors & Collaborators

  • Copenhagen Municipality, Denmark

    collaborator OTHER_GOV
  • Municipality of Frederiksberg, Denmark

    collaborator UNKNOWN
  • Center for Clinical Research and Prevention

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2026-04-30
Completion
2026-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07248241 on ClinicalTrials.gov